EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 01, 2023
- Source ID
- 10.1016/j.lungcan.2023.107250
Entities
People
- Daniel B Costa
- Daniel Sentana-lledo
- Deepa Rangachari
- Ikei S. Kobayashi
- Meghan D. Lee
- Paul A. Vanderlaan
- Shriram Sundararaman
- Susumu S Kobayashi
- William Shaffer
Organizations
- National Cancer Institute
- National Institutes of Health
- United States Department of Defense